{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:30:54Z","timestamp":1792225854959,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T00:00:00Z","timestamp":1483315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12288-016-0773-9","type":"journal-article","created":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T15:49:31Z","timestamp":1483372171000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference"],"prefix":"10.1007","volume":"33","author":[{"name":"for IMAGe Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Yanamandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khattry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noopur","family":"Raje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arihant","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundar","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,2]]},"reference":[{"issue":"1","key":"773_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1414214","volume":"373","author":"KS Reddy","year":"2015","unstructured":"Reddy KS (2015) India\u2019s aspirations for Universal Health coverage. N Engl J Med 373(1):1\u20135","journal-title":"N Engl J Med"},{"issue":"10","key":"773_CR2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV (2010) Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 85(10):933\u2013942","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"773_CR3","first-page":"3","volume":"6","author":"AP Meher Lakshmi Konatam","year":"2016","unstructured":"Meher Lakshmi Konatam AP, Sadashivudu G (2016) Age of onset of multiple myeloma: a Paradigm shift in Indian patients Indian. J Appl Res 6(10):3","journal-title":"J Appl Res"},{"issue":"1","key":"773_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3322\/caac.21261","volume":"65","author":"RA Smith","year":"2015","unstructured":"Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D et al (2015) Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 65(1):30\u201354","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"773_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.24236","volume":"91","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV (2016) Myeloma today: disease definitions and treatment advances. Am J Hematol 91(1):90\u2013100","journal-title":"Am J Hematol"},{"issue":"12","key":"773_CR6","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.humpath.2007.04.010","volume":"38","author":"SZ Al-Quran","year":"2007","unstructured":"Al-Quran SZ, Yang L, Magill JM, Braylan RC, Douglas-Nikitin VK (2007) Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry. Hum Pathol 38(12):1779\u20131787","journal-title":"Hum Pathol"},{"issue":"11","key":"773_CR7","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3324\/haematol.2009.009100","volume":"94","author":"B Paiva","year":"2009","unstructured":"Paiva B, Vidriales MB, Perez JJ, Mateo G, Montalban MA, Mateos MV et al (2009) Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients. Haematologica 94(11):1599\u20131602","journal-title":"Haematologica"},{"key":"773_CR8","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/bcj.2015.92","volume":"5","author":"AM Rajan","year":"2015","unstructured":"Rajan AM, Rajkumar SV (2015) Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer J 5:e365","journal-title":"Blood Cancer J"},{"issue":"18","key":"773_CR9","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","volume":"117","author":"M Dimopoulos","year":"2011","unstructured":"Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A et al (2011) Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 117(18):4701\u20134705","journal-title":"Blood"},{"key":"773_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/asheducation-2015.1.279","volume":"2015","author":"T Facon","year":"2015","unstructured":"Facon T (2015) Maintenance therapy for multiple myeloma in the era of novel agents. Hematol Am Soc Hematol Educ Prog 2015:279\u2013285","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"issue":"20","key":"773_CR11","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2014-09-568915","volume":"125","author":"P Moreau","year":"2015","unstructured":"Moreau P, Attal M, Facon T (2015) Frontline therapy of multiple myeloma. Blood 125(20):3076\u20133084","journal-title":"Blood"},{"issue":"6","key":"773_CR12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2014-03-544759","volume":"124","author":"MA Gertz","year":"2014","unstructured":"Gertz MA, Dingli D (2014) How we manage autologous stem cell transplantation for patients with multiple myeloma. Blood 124(6):882\u2013890","journal-title":"Blood"},{"issue":"4","key":"773_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/bmt.2015.325","volume":"51","author":"B Dhakal","year":"2016","unstructured":"Dhakal B, Vesole DH, Hari PN (2016) Allogeneic stem cell transplantation for multiple myeloma: is there a future? Bone Marrow Transp 51(4):492\u2013500","journal-title":"Bone Marrow Transp"},{"issue":"1","key":"773_CR14","first-page":"16","volume":"16","author":"L Kumar","year":"2003","unstructured":"Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J et al (2003) High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Natl Med J India 16(1):16\u201321","journal-title":"Natl Med J India"},{"issue":"12","key":"773_CR15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/bmt.2009.75","volume":"43","author":"M Trivedi","year":"2009","unstructured":"Trivedi M, Martinez S, Corringham S, Medley K, Ball ED (2009) Optimal use of G-CSF administration after hematopoietic SCT. Bone Marrow Transp 43(12):895\u2013908","journal-title":"Bone Marrow Transp"},{"issue":"21","key":"773_CR16","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V118.21.3983.3983","volume":"118","author":"C Chen","year":"2011","unstructured":"Chen C, Rabea AM, Masih-Khan E, Chu C-M, Kukreti V, Trudel S et al (2011) Central Nervous System (CNS) Involvement with Multiple Myeloma (MM)\u2013Longterm Survival Can Be Achieved with Radiation, Intrathecal (IT) Chemotherapy, and Immunomodulatory Agents (IMiDs). Blood. 118(21):3983","journal-title":"Blood."},{"issue":"13","key":"773_CR17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E et al (2016) International myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol 34(13):1544\u20131557","journal-title":"J Clin Oncol"},{"issue":"2","key":"773_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbo.2013.04.001","volume":"2","author":"R Silbermann","year":"2013","unstructured":"Silbermann R, Roodman GD (2013) Myeloma bone disease: pathophysiology and management. J Bone Oncol 2(2):59\u201369","journal-title":"J Bone Oncol"},{"issue":"12","key":"773_CR19","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/leu.2012.124","volume":"26","author":"DH Vesole","year":"2012","unstructured":"Vesole DH, Oken MM, Heckler C, Greipp PR, Katz MS, Jacobus S et al (2012) Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC\/ECOG randomized phase III study. Leukemia 26(12):2517\u20132520","journal-title":"Leukemia"},{"issue":"9","key":"773_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clml.2016.06.006","volume":"16","author":"A Alemu","year":"2016","unstructured":"Alemu A, Richards JO, Oaks MK, Thompson MA (2016) Vaccination in multiple myeloma: review of current literature. Clin Lymphoma Myeloma Leuk 16(9):495\u2013502","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-016-0773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-016-0773-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-016-0773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T12:04:31Z","timestamp":1601294671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-016-0773-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1007\/s12288-016-0773-9","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]}}}